UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD
ENDED JUNE 30, 2003
OR
[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD
FROM ____________ TO ____________
COMMISSION FILE NUMBER 000-26124
IXYS CORPORATION
| DELAWARE | 77-0140882 | |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
3540 BASSETT STREET
SANTA CLARA, CALIFORNIA 95054-2704
(Address of principal executive offices and Zip Code)
(408) 982-0700
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [_]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes [X] No [_]
THE NUMBER OF SHARES OF THE REGISTRANTS COMMON STOCK, $0.01 PAR VALUE, OUTSTANDING AS OF AUGUST 8, 2003, WAS 31,900,413.
IXYS CORPORATION
FORM 10-Q
June 30, 2003
INDEX
| Page No. | |||
PART I FINANCIAL INFORMATION |
|||
ITEM 1. FINANCIAL STATEMENTS |
3 | ||
CONDENSED CONSOLIDATED BALANCE SHEETS |
3 | ||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
4 | ||
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME |
5 | ||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
6 | ||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS |
7 | ||
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS |
14 | ||
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
28 | ||
ITEM 4. CONTROLS AND PROCEDURES |
28 | ||
PART II OTHER INFORMATION |
|||
ITEM 1. LEGAL PROCEEDINGS |
30 | ||
ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS |
31 | ||
ITEM 3. DEFAULTS UPON SENIOR SECURITIES |
31 | ||
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
31 | ||
ITEM 5. OTHER INFORMATION |
31 | ||
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K |
31 | ||
SIGNATURES |
32 | ||
2
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
IXYS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
| June 30, | March 31, | ||||||||||||
| 2003 | 2003 | ||||||||||||
| (unaudited) | |||||||||||||
ASSETS |
|||||||||||||
Current assets: |
|||||||||||||
Cash and cash equivalents |
$ | 41,733 | $ | 40,094 | |||||||||
Restricted cash |
2,628 | 2,748 | |||||||||||
Accounts receivable, net of allowance for doubtful
accounts of $3,582 at June 30, 2003 and $3,169 at
March 31, 2003 |
23,234 | 21,475 | |||||||||||
Inventories |
51,217 | 49,162 | |||||||||||
Prepaid expenses and other current assets |
960 | 943 | |||||||||||
Deferred income taxes |
10,172 | 10,285 | |||||||||||
Total current assets |
129,944 | 124,707 | |||||||||||
Plant and equipment, net |
28,249 | 28,715 | |||||||||||
Other assets |
5,642 | 5,655 | |||||||||||
Deferred income taxes |
2,789 | 2,563 | |||||||||||
Goodwill |
21,417 | 21,417 | |||||||||||
Total assets |
$ | 188,041 | $ | 183,057 | |||||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
|||||||||||||
Current liabilities: |
|||||||||||||
Current portion of capitalized lease obligations |
$ | 3,490 | $ | 3,238 | |||||||||
Current portion of notes payable to bank |
800 | 700 | |||||||||||
Accounts payable |
14,099 | 11,177 | |||||||||||
Accrued expenses and other liabilities |
14,920 | 14,167 | |||||||||||
Total current liabilities |
33,309 | 29,282 | |||||||||||
Capitalized lease and other long-term obligations,
net of current portion |
4,397 | 5,042 | |||||||||||
Pension liabilities |
10,523 | 9,924 | |||||||||||
Total liabilities |
48,229 | 44,248 | |||||||||||
Commitments and contingencies (Note 11) |
|||||||||||||
Stockholders Equity |
|||||||||||||
Preferred stock, $0.01 par value: |
|||||||||||||
Authorized: 5,000,000 shares; none
issued and outstanding |
|||||||||||||
Common stock, $0.01 par value: |
|||||||||||||
Authorized: 80,000,000 shares
issued and outstanding: 31,994,586
shares at June 30, 2003 and
31,957,182 shares at March 31, 2003 |
320 | 320 | |||||||||||
Additional paid-in capital |
145,085 | 144,835 | |||||||||||
Deferred compensation |
(18 | ) | (26 | ) | |||||||||
Notes receivable from stockholders |
(913 | ) | (913 | ) | |||||||||
Accumulated deficit |
(5,875 | ) | (6,318 | ) | |||||||||
Less cost of treasury stock: 95,302 shares at June 30,
2003 and at March 31, 2003 |
(447 | ) | (447 | ) | |||||||||
Accumulated other comprehensive income |
1,660 | 1,358 | |||||||||||
Total stockholders equity |
139,812 | 138,809 | |||||||||||
Total liabilities and stockholders equity |
$ | 188,041 | $ | 183,057 | |||||||||
The accompanying notes are an integral part of these condensed consolidated
financial statements.
3
IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
| Three Months Ended | |||||||||||
| June 30, | |||||||||||
| 2003 | 2002 | ||||||||||
| (unaudited) | |||||||||||
Net revenues |
$ | 40,096 | $ | 27,437 | |||||||
Cost of goods sold |
27,755 | 21,061 | |||||||||
Gross profit |
12,341 | 6,376 | |||||||||
Operating expenses: |
|||||||||||
Research, development and
engineering |
4,035 | 2,186 | |||||||||
Selling, general and administrative |
6,489 | 5,205 | |||||||||
Total operating expenses |
10,524 | 7,391 | |||||||||
Operating income (loss) |
1,817 | (1,015 | ) | ||||||||
Interest income |
112 | 203 | |||||||||
Interest expense |
(36 | ) | (39 | ) | |||||||
Other (expense) income, net |
(1,211 | ) | (1,352 | ) | |||||||
Income (loss) before income tax benefit (provision) |
682 | (2,203 | ) | ||||||||
Benefit from (provision for) income tax |
(239 | ) | 785 | ||||||||
Net income (loss) |
$ | 443 | $ | (1,418 | ) | ||||||
Net income (loss) per share basic |
$ | 0.01 | $ | (0.05 | ) | ||||||
Weighted average shares used in per share calculation
Basic |
31,972 | 27,999 | |||||||||
Net income (loss) per share diluted |
$ | 0.01 | $ | (0.05 | ) | ||||||
Weighted average shares used in per share calculation
Diluted |
33,116 | 27,999 | |||||||||
The accompanying notes are an integral part of these condensed consolidated
financial statements.
4
IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
| Three Months Ended | |||||||||
| June 30, | |||||||||
| 2003 | 2002 | ||||||||
| (unaudited) | |||||||||
Net income (loss) |
$443 | $ | (1,418 | ) | |||||
Other comprehensive income: |
|||||||||
Foreign currency translation
adjustments |
302 | 2,974 | |||||||
Comprehensive income |
$745 | $ | 1,556 | ||||||
The accompanying notes are an integral part of these condensed consolidated
financial statements.
5
IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Three Months Ended | ||||||||||
| June 30, | ||||||||||
| 2003 | 2002 | |||||||||
| (unaudited) | ||||||||||
Cash flows from operating activities: |
||||||||||
Net income (loss) |
$ | 443 | $ | (1,418 | ) | |||||
Adjustments to reconcile net income (loss) to net
cash provided by operating activities: |
||||||||||
Depreciation |
2,141 | 1,409 | ||||||||
Amortization of intangible assets |
212 | 90 | ||||||||
Provision for doubtful accounts |
390 | 291 | ||||||||
Deferred income taxes |
(174 | ) | (1,039 | ) | ||||||
Gain (loss) on foreign currency transactions |
(485 | ) | 38 | |||||||
Changes in operating assets and liabilities : |
||||||||||
Accounts receivable |
(1,340 | ) | (1,307 | ) | ||||||
Inventories |
(1,968 | ) | 3,268 | |||||||
Prepaid expenses and other current assets |
43 | (986 | ) | |||||||
Other assets |
(355 | ) | (889 | ) | ||||||
Accounts payable |
2,524 | 1,246 | ||||||||
Accrued expenses and other liabilities |
469 | (759 | ) | |||||||
Pension liabilities |
833 | 123 | ||||||||
Net cash provided by operating activities |
2,733 | 67 | ||||||||
Cash flows from investing activities: |
||||||||||
Restricted cash |
120 | (114 | ) | |||||||
Net cash acquired in acquisition of Clare, Inc. |
| 7,906 | ||||||||
Cash received for tax refund claims acquired from
Clare, Inc. |
| 2,500 | ||||||||
Purchase of plant and equipment |
(1,271 | ) | (63 | ) | ||||||
Net cash provided by (used in)
investing activities |
(1,151 | ) | 10,229 | |||||||
Cash flows from financing activities: |
||||||||||
Proceeds from capital lease obligations |
210 | | ||||||||
Principal payments on capital lease obligations |
(784 | ) | (722 | ) | ||||||
Proceeds from exercise of options |
74 | 68 | ||||||||
Proceeds from issuance of shares under ESPP |
181 | 112 | ||||||||
Net cash used in financing activities |
(319 | ) | (542 | ) | ||||||
Effect of foreign exchange rate fluctuations on
cash and cash equivalents |
376 | 986 | ||||||||
Net increase in cash and cash
Equivalents |
1,639 | 10,740 | ||||||||
Cash and cash equivalents at beginning of period |
40,094 | 32,111 | ||||||||
Cash and cash equivalents at end of period |
$ | 41,733 | $ | 42,851 | ||||||
The accompanying notes are an integral part of these condensed consolidated
financial statements.
6
IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Condensed Consolidated Financial Statements
The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The condensed consolidated financial statements include the accounts of IXYS Corporation (IXYS or the Company) and its wholly-owned subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require managements most difficult judgments include: assessment of recoverability of goodwill, valuation of property, plant and equipment, valuation of inventory, and the recognition and measurement of income tax assets and liabilities. All significant intercompany transactions have been eliminated in consolidation. All adjustments of a normal recurring nature that, in the opinion of management, are necessary for a fair statement of the results for the interim periods have been made. It is recommended that the interim financial statements be read in conjunction with the Companys audited consolidated financial statements and notes thereto for the fiscal year ended March 31, 2003 contained in the Companys Annual Report on Form 10-K. Interim results are not necessarily indicative of the operating results expected for later quarters or the full fiscal year. Certain reclassifications have been made to the prior periods condensed consolidated financial statements to conform to the current periods presentation. Such reclassifications had no effect on previously reported results of operations or retained earnings.
2. Warranty
The Company generally sells products with a limited warranty of product quality and a limited indemnification of customers against intellectual property infringements claims related to the Companys products. The Company accrues for known warranty and indemnification issues if a loss is probable and can be reasonably estimated, and accrues for estimated but incurred and unidentified issues based on historical activity. Actual warranty costs incurred have not materially differed from those accrued. IXYSs warranty policy is effective for shipped products which are considered defective or fail to meet the product specifications. IXYS analyzes historical claims compared to historical revenue in evaluating the adequacy of the warranty allowance. Warranty costs are reflected in the income statement as a cost of revenues. There was no material change in the warranty provision for the three month period ending June 30, 2003.
3. Accounting for Stock-Based Compensation
The Company has a stock option plan under which officers, key employees and non-employee directors may be granted options to purchase shares of the Companys authorized but unissued common stock. Options granted by IXYS currently expire no later than 10 years from the grant date. Currently, options granted to existing and newly hired employees generally vest in increments over four years from the date of grant. In addition to the stock option plans, the Company also has an Employee Stock Purchase Plan, under which eligible employees may purchase shares of IXYSs common stock at 85% of fair market value at specific, predetermined dates.
Statement of Financial Accounting Standards No. 148, Accounting for Stock-Based Compensation Transition and Disclosure, an Amendment of FASB Statement No. 123 (SFAS No. 148) provides alternative methods of transition for companies making a voluntary change to fair value-based accounting for stock-based employee compensation. SFAS No. 148 also requires disclosure of pro-forma results on a quarterly basis as if the company had applied the fair value recognition provisions of SFAS No. 123. IXYS continues to account for its stock option plans under the intrinsic value recognition and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations.
As the exercise price of all options granted under these plans was equal to the market price of the underlying common stock on the grant date, no stock-based employee compensation, other than acquisition-related compensation, is recognized in net income. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123, as amended, to options granted under the stock option plans and rights to acquire stock granted under the Companys Employee Stock Purchase Plan, collectively called options. For purposes of this pro-forma disclosure, the value of the options is estimated using a Black-Scholes option pricing model and amortized ratably to expense over the options vesting periods. Because the estimated value is determined as of the date of grant, the actual value ultimately realized by the employee may be significantly different.
7
IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| Three Months Ended June 30, | ||||||||
| 2003 | 2002 | |||||||
| (in thousands, except share
data) (unaudited) |
||||||||
Net Income (loss), as reported |
$ | 443 | $ | (1,418 | ) | |||
Less: Total stock based compensation expense
determined under fair value based method for
all awards to employees |
(238 | ) | (128 | ) | ||||
Pro forma net income (loss) |
$ | 205 | $ | (1,546 | ) | |||
Basic and diluted net income (loss) per share: |
||||||||
As reported |
$ | 0.01 | $ | (0.06 | ) | |||
Pro forma |
$ | 0.01 | $ | (0.06 | ) | |||
SFAS No. 123 requires the use of option pricing models that were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the options expected life and the price volatility of the underlying stock. Because the Companys employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in the opinion of management, the existing models do not necessarily provide a reliable single measure of the fair value of employee stock options.
4. Acquisition of Clare, Inc.
On June 10, 2002, IXYS completed its acquisition of Clare, Inc. (Clare), a manufacturer of high-performance analog and mixed-signal integrated circuits based in the United States. The acquisition of Clare was intended to allow the combined organization to be more competitive and to achieve greater financial strength, operational efficiencies, access to capital and growth potential than either company could separately achieve. In connection with the acquisition, (a) each outstanding share of Clare common stock was converted into the right to receive 0.49147 of a share of IXYS common stock, which resulted in the issuance of approximately 4.89 million shares of IXYS common stock, and (b) each option to purchase Clare common stock outstanding immediately prior to the consummation of the acquisition was converted into an option to purchase 0.49147 of a share of IXYS common stock, resulting in the assumption of options exercisable for approximately 1.0 million shares of IXYS common stock. The estimated total purchase price is as follows (in thousands):
Value of IXYS common stock issued |
$ | 47,658 | |||
Value of Clares options assumed by IXYS |
3,679 | ||||
Merger cost |
1,738 | ||||
Total purchase price |
$ | 53,075 | |||
IXYS has finalized the fair values of identifiable intangible assets acquired and plant and equipment. Replacement cost has been used to determine the fair value of the plant and equipment acquired. IXYS has allocated the purchase price to identifiable intangible assets, tangible assets, liabilities assumed and goodwill as follows (in thousands):
Value of IXYS common stock issued |
$ | 47,658 | |||
Value of Clares options assumed by IXYS |
3,679 | ||||
Merger cost |
1,738 | ||||
Total purchase price |
$ | 53,075 | |||
Fair Value of tangible assets acquired: |
|||||
Current assets |
$ | 24,861 | |||
Deferred tax assets short term |
2,742 | ||||
Plant and equipment |
10,271 | ||||
Other assets |
111 | ||||
| $ | 37,985 | ||||
| Amortizable intangible assets: | Estimated Useful Lives | ||||||||
Core technology |
2,700 | 5 to 6 years | |||||||
Tradename/trademarks |
900 | 3 years | |||||||
Other |
715 | 3 months to 6 years | |||||||
| 4,315 | |||||||||
Total assets acquired |
42,300 | ||||||||
8
IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Fair value of liabilities assumed |
(8,746 | ) | |||
Net assets acquired |
33,554 | ||||
Goodwill |
19,521 | ||||
Total purchase price |
$ | 53,075 | |||
Pro Forma Disclosure (in thousands, except per share data):
The following unaudited pro forma combined amounts give effect to the acquisition of Clare as if the acquisition had occurred on April 1, 2002. On a pro forma basis, the results of operations of Clare for the three-month period ended June 30, 2002 are consolidated with IXYS results for the three-month period ended June 30, 2002. The pro forma amounts do not purport to be indicative of what would have occurred had the acquisition been made as of the beginning of the period or of results which may occur in the future.
| Three Months Ended | ||||
| June 30, 2002 | ||||
Revenue |
$ | 33,893 | ||
Net loss |
(9,201 | ) | ||
Net loss per share basic and diluted |
$ | (0.29 | ) | |
Shares used in per share calculation |
31,817 | |||
5. New and Recently Effective Accounting Pronouncements
In January 2003, the FASB issued FIN 46, Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51. FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective immediately for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provision of FIN 46 must be applied for the first interim or annual period beginning after June 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.
In April 2003, the FASB issued SFAS No. 149, Amendment of Statement 133 of Derivative Instruments and Hedging Activities. SFAS No. 149 amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts. This standard is effective for contracts entered into or modified after June 30, 2003. IXYS adopted this standard and the adoption of this standard had no material impact on its financial statements.
9
IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
In May 2003, the FASB issued SFAS No. 150, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity. SFAS No. 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. SFAS No. 150 is to be implemented by reporting the cumulative effect of a change in an accounting principle for financial instruments created before the issuance date of the statement and still existing at the beginning of the interim period of adoption. The Company does not expect the adoption of SFAS No. 150 to have a significant impact on its financial position or results of operations.
8. Inventories
Inventories consist of the following (in thousands):
| June 30, | March 31, | |||||||
| 2003 | 2003 | |||||||
| (unaudited) | ||||||||
Raw materials |
$ | 8,184 | $ | 8,765 | ||||
Work in process |
29,639 | 31,842 | ||||||
Finished goods |
13,394 | |||||||